Variant report
Variant | nsv971201 |
---|---|
Chromosome Location | chr7:21028141-21034740 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:21028658..21031192-chr7:21285950..21288687,2 | MCF-7 | breast: | |
2 | chr7:21030959..21031728-chr7:21293405..21294297,3 | MCF-7 | breast: | |
3 | chr7:21030868..21031815-chr7:21293621..21294401,4 | MCF-7 | breast: | |
4 | chr7:21030941..21031589-chr7:21290459..21291400,3 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ABCB5-1 | chr7:21032500-21033057 | NONHSAT119439 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536105056 | chr7:21028192-21028193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs118183193 | chr7:21028193-21028194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369216031 | chr7:21028254-21028255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575928134 | chr7:21028263-21028264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs59962015 | chr7:21028269-21028270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs199787507 | chr7:21028270-21028271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371424183 | chr7:21028271-21028272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200162959 | chr7:21028274-21028275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563318751 | chr7:21028374-21028375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576815475 | chr7:21028389-21028390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545891931 | chr7:21028393-21028394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs17143639 | chr7:21028402-21028403 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs528267107 | chr7:21028432-21028433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548007631 | chr7:21028451-21028452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35462998 | chr7:21028456-21028457 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs181200408 | chr7:21028464-21028465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146107400 | chr7:21028484-21028485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139117534 | chr7:21028485-21028486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149902042 | chr7:21028494-21028495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547115897 | chr7:21028497-21028498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369354422 | chr7:21028503-21028504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536460075 | chr7:21028525-21028526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73269804 | chr7:21028614-21028615 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs536043414 | chr7:21028618-21028619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs36033277 | chr7:21028739-21028740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556012398 | chr7:21028812-21028813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547537982 | chr7:21028833-21028834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183922199 | chr7:21028834-21028835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144910272 | chr7:21028835-21028836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188155549 | chr7:21028927-21028928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181991755 | chr7:21028952-21028953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377231415 | chr7:21028963-21028964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186300788 | chr7:21028974-21028975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559002087 | chr7:21029001-21029002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572635120 | chr7:21029035-21029036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541588413 | chr7:21029044-21029045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561938945 | chr7:21029086-21029087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530677272 | chr7:21029145-21029146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550844237 | chr7:21029158-21029159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564273656 | chr7:21029186-21029187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533340440 | chr7:21029207-21029208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547051167 | chr7:21029228-21029229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368774187 | chr7:21029239-21029240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566937858 | chr7:21029240-21029241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529431003 | chr7:21029306-21029307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs148605865 | chr7:21029329-21029330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10250802 | chr7:21029343-21029344 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs569442969 | chr7:21029356-21029357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144172193 | chr7:21029375-21029376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558423986 | chr7:21029420-21029421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 16773561 | CNVD |
Schizophrenia | 19546859 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:21026800-21028400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr7:21028000-21028600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr7:21028400-21028600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr7:21028600-21031400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
5 | chr7:21028600-21032200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
6 | chr7:21031200-21031400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr7:21031400-21031600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr7:21031400-21031800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr7:21031800-21032800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr7:21033000-21033200 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
11 | chr7:21033200-21033600 | ZNF genes & repeats | ES-WA7 Cell Line | embryonic stem cell |
12 | chr7:21033600-21037800 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
13 | chr7:21034000-21037600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |